Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 20, 2021

View Archived Issues

TRIM47 targeting shows potential for treating breast cancer refractory to endocrine therapy

Gilead describes new antiviral nucleoside analogues

New GCN2 inhibitors identified at Black Belt TX

As targeted options expand, making the best match, and the most matches

Targeting GCN2 or elevating tRNAGly levels may be useful in Charcot-Marie-Tooth disease

IP6K regulates circulating phosphate and intracellular ATP in mammals

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents antibodies binding IL-4RA

Single-cell transcriptome of human melanocytes during development, aging and malignancy

Discovery of novel compounds with potent activity against resistant bacteria

TSHA-104 AAV9 gene-replacement therapy for Leigh syndrome shows promising results

MEGs and MBK-2 clusters regulate P granule dynamics and coarsening

Rasarfin, a dual Ras and ARF6 inhibitor with promising antitumor activity

NIDA agrees to screen Initiator Pharma's preclinical assets for anti-addictive properties

Researchers report improved DHODH inhibitors, anti-coronavirus activity

Kissei Pharmaceutical discovers EGLN1 inhibitors

SpectrumX reports in vitro neutralizing efficacy of SPC-069 against SARS-CoV-2 variants

ETX-0462 is a potent antibiotic against Pseudomonas aeruginosa

BET protein inhibition can reverse CAR T-cell exhaustion

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...